|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/44 | |
| A61K 31/675 | |||
| A61K 31/444 | |||
| A61P 35/00 |
| (11) | Number of the document | 2224925 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08863324.3 |
| Date of filing the European patent application | 2008-12-12 | |
| (97) | Date of publication of the European application | 2010-09-08 |
| (45) | Date of publication and mention of the grant of the patent | 2015-09-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/SE2008/051450 |
| Date | 2008-12-12 |
| (87) | Number | WO 2009/078794 |
| Date | 2009-06-25 |
| (30) | Number | Date | Country code |
| 6010 | 2007-12-14 | US |
| (72) |
KARLSSON, Jan Olof G., NO
KURZ, Tino, SE
ANDERSSON, Rolf, SE
|
| (73) |
Pledpharma AB,
Grev Turegatan 7, 114 46 Stockholm,
SE
|
| (54) | COMPOUNDS FOR USE IN THE TREATMENT OF CANCER |
| COMPOUNDS FOR USE IN THE TREATMENT OF CANCER |